Berberine reduces leukocyte adhesion to lps-stimulated endothelial cells and vcam-1 expression both in vivo and in vitro

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 3, 2012, Pages 741-750

  Wu, Y H ^a,b   Chuang, S Y ^a   Hong, W C ^a,b   Lai, Y J ^b   Chang, G J ^a   Pang, J H S ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Berberine; Endothelial cells; Lipopolysaccharides; Lung injury; Nuclear factor kappa b; Vascular cell adhesion molecule 1

Indexed keywords

BERBERINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; RNA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ADHERENCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84868010752     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500320     Document Type: Article

References (30)

1. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008; 57:712-7. (Pubitemid 351608234)
2. Xie W, Du L. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes Metab 2011; 13: 289-301.
3. Affuso F, Mercurio V, Fazio V, Fazio S. Cardiovascular and metabolic effects of Berberine. World J Cardiol 2010; 2: 71-7.
4. Vuddanda PR, Chakraborty S, Singh S. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs 2010; 19: 1297-307.
5. Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 2008; 93:2559-65. (Pubitemid 352008520)
6. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10:1344-51. (Pubitemid 40022716)
7. Kong WJ, Wei J, Zuo ZY, et al. Combination of simvastatin with berberine improves the lipidlowering efficacy. Metabolism 2008; 57:1029-37. (Pubitemid 351978060)
8. Zhang HQ, Wang HD, Lu DX, Qi RB, Wang YP, Yan YX, Fu YM. Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2adrenergic receptor in mice. Shock 2008; 29: 617-22.
9. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-54. (Pubitemid 36437931)
10. Costa EL, Schettino IA, Schettino GP. The lung in sepsis: guilty or innocent. Endocr Metab Immune Disord Drug Targets 2006; 6: 213-6.
11. Lium B, Aasen AO, Saugstad OD, Guldvog I, Nordstoga K, Amundsen E. Experimental posttraumatic lung insufficiency in dogs: ultrastructure of lung lesions. Acta Pathol Microbiol Immunol Scand A 1982; 90:113-23. (Pubitemid 12136216)
12. Bannerman DD, Goldblum SE. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest 1999; 79:1181-99. (Pubitemid 29489444)
13. Hoover RL, Briggs RT, Karnovsky MJ. The adhesive interaction between polymorphonuclear leukocytes and endothelial cells in vitro. Cell 1978; 14:423-8. (Pubitemid 8369842)
14. Parent C, Eichacker PQ. Neutrophil and endothelial cell interactions in sepsis. The role of adhesion molecules. Infect Dis Clin North Am 1999; 13:427-47. (Pubitemid 29248754)
15. Shanley TP, Warner RL, Ward PA. The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1995; 1: 40-5.
16. Ye X, Ding J, Zhou X, Chen G, Liu SF. Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis. J Exp Med 2008; 205:1303-15. (Pubitemid 351831488)
17. Nachman RL, Jaffe EA. Endothelial cell culture: beginnings of modern vascular biology. J Clin Invest 2004; 114:1037-40. (Pubitemid 39578688)
18. Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoč 2007; 2:481-5. (Pubitemid 47040010)
19. Cheung AL. Isolation and culture of human umbilical vein endothelial cells (HUVEC). Curr Protoč Microbiol 2007; Appendix 4, Appendix 4B.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 1987; 162:156-9. (Pubitemid 17064313)
21. Pang JH, Hung RY, Wu CJ, Fang YY, Chau LY Functional characterization of the promoter region of the platelet-activating factor receptor gene. J Biol Chem 1995; 270: 14123-9.
22. Kiely JM, Luscinskas FW, Gimbrone M A Jr. Leukocyte-endothelial monolayer adhesion assay (static conditions). Methods Mol Biol 1999; 96: 131-6
23. Lee JS, Park SY, Thapa D, Kim AR, Shin HM, Kim JA. HMC05, Herbal Formula, inhibits TNF-{alpha}induced inflammatory response in human umbilical vein endothelial cells. Evid Based Complement Alternat Med 2009; [ Epub ahead of print].
24. Marui N, Offermann, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92:1866-74. (Pubitemid 23304554)
25. Tsushima K, King LS, Aggarwal NR, De Gorordo A, D'Alessio FR, Kubo K. Acute lung injury review. Intern Med 2009; 48: 621-30.
26. Hack CE, Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 2001; 29:S21-7. (Pubitemid 32681578)
27. Harlan JM. Leukocyte-endothelial interactions. Blood 1985; 65: 513-25.
28. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068-101. (Pubitemid 24296363)
29. Liu Y, Yu H, Zhang C, Cheng Y, Hu L, Meng X, Zhao Y. Protective effects of berberine on radiationinduced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur J Cancer 2008; 44: 2425-32.
30. Mazzini S, Bellucci MC, Mondelli R. Mode of binding of the cytotoxic alkaloid berberine with the double helix oligonucleotide d(AAGAATTCTT)(2). Bioorg Med Chem 2003; 11:505-14. (Pubitemid 36132227)